Compare Alphabet Inc Class A (GOOGL) vs Novartis AG (NVS) Price & Performance

Alphabet Inc Class ATrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

Alphabet Inc Class A vs Novartis AG — how do they compare? Alphabet Inc Class A trades at $341.5 (market cap $4.20T), while Novartis AG trades at $153.01 (market cap $295.37B). The key difference: Alphabet Inc Class A is far larger — about 14.2× Novartis AG's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.

	GOOGL	NVS
Market Cap	$4.20T	$295.37B
Sector	Media	Health
52-Week High	$402.62	$168.62
52-Week Low	$199.32	$119.31
Enterprise Value	$4.09T	$336.69B
Dividend Yield	0.26%	3.07%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alphabet Inc Class A

Alphabet (GOOGL) trades at $357.52, up 0.91% today, with a bullish technical signal from moving averages and strong support at $354. The stock shows robust fundamentals, with revenue growing from $350.0B in 2024 to $402.8B in 2025 (SEC filings, 2025), net income margin expanding to 32.8%, and consistent earnings beats. Recent news highlights AI-driven growth opportunities, including partnerships and YouTube price increases (Reuters, 2026-04-10).

Outlook remains positive with an 85% analyst buy rating and $426.28 consensus price target (MarketBeat, 2026-04-11), though risks include antitrust scrutiny and tech sector volatility. Earnings growth and AI integration are key catalysts for upside, while competition and regulatory pressures warrant monitoring.

Novartis AG

Novartis AG (NVS) trades at $156.79, up 0.29% today, with a bullish technical signal from moving averages and recent Q2 2026 earnings beating estimates. Strong profitability is evident with a 74.74% gross margin and 22.5% net margin, while revenue grew to $56.67B in 2025. The stock faces resistance near $157, with support at $156.

The outlook is positive due to robust drug pipeline progress and reaffirmed 2026 guidance, though risks include generic competition for Entresto and pricing pressures. Analyst sentiment is mixed with 24% buy ratings, but institutional buying activity supports confidence in long-term growth.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GOOGL

Google unveils Pixel 11 series, Pixel Watch 5, and Pixel Tag tracker with new AI features.TechCrunch · 5 hours agoBullish Google's Quick Share adds tap-to-share mode for faster Android device sharingTechCrunch · 5 hours agoBullish Google launches Pixel Watch 5 with advanced health tracking and smarter AI features starting at $399TechCrunch · 5 hours agoBullish View details →

NVS

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

About Alphabet Inc Class A

Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.